170 related articles for article (PubMed ID: 19763275)
1. VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation.
Dawson MR; Duda DG; Chae SS; Fukumura D; Jain RK
PLoS One; 2009 Sep; 4(9):e6525. PubMed ID: 19763275
[TBL] [Abstract][Full Text] [Related]
2. C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells.
Hiratsuka S; Duda DG; Huang Y; Goel S; Sugiyama T; Nagasawa T; Fukumura D; Jain RK
Proc Natl Acad Sci U S A; 2011 Jan; 108(1):302-7. PubMed ID: 21173223
[TBL] [Abstract][Full Text] [Related]
3. VEGFR1-activity-independent metastasis formation.
Dawson MR; Duda DG; Fukumura D; Jain RK
Nature; 2009 Sep; 461(7262):E4; discussion E5. PubMed ID: 19759568
[TBL] [Abstract][Full Text] [Related]
4. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
5. Premetastatic lung "niche": is vascular endothelial growth factor receptor 1 activation required?
Duda DG; Jain RK
Cancer Res; 2010 Jul; 70(14):5670-3. PubMed ID: 20587530
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor receptor 1 (VEGFR1) tyrosine kinase signaling facilitates granulation tissue formation with recruitment of VEGFR1
Park K; Amano H; Ito Y; Mastui Y; Kamata M; Yamazaki Y; Takeda A; Shibuya M; Majima M
Anat Sci Int; 2018 Jun; 93(3):372-383. PubMed ID: 29256114
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived vascular endothelial growth factor (VEGF)-a facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway.
Liu W; Xu J; Wang M; Wang Q; Bi Y; Han M
Int J Oncol; 2011 Nov; 39(5):1213-20. PubMed ID: 21785819
[TBL] [Abstract][Full Text] [Related]
8. CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis.
Chen XW; Yu TJ; Zhang J; Li Y; Chen HL; Yang GF; Yu W; Liu YZ; Liu XX; Duan CF; Tang HL; Qiu M; Wang CL; Zheng H; Yue J; Guo AM; Yang J
Oncogene; 2017 Aug; 36(35):5045-5057. PubMed ID: 28481877
[TBL] [Abstract][Full Text] [Related]
9. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
Kaplan RN; Riba RD; Zacharoulis S; Bramley AH; Vincent L; Costa C; MacDonald DD; Jin DK; Shido K; Kerns SA; Zhu Z; Hicklin D; Wu Y; Port JL; Altorki N; Port ER; Ruggero D; Shmelkov SV; Jensen KK; Rafii S; Lyden D
Nature; 2005 Dec; 438(7069):820-7. PubMed ID: 16341007
[TBL] [Abstract][Full Text] [Related]
10. Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells.
Tam J; Duda DG; Perentes JY; Quadri RS; Fukumura D; Jain RK
PLoS One; 2009; 4(3):e4974. PubMed ID: 19333381
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.
Kusmartsev S; Eruslanov E; Kübler H; Tseng T; Sakai Y; Su Z; Kaliberov S; Heiser A; Rosser C; Dahm P; Siemann D; Vieweg J
J Immunol; 2008 Jul; 181(1):346-53. PubMed ID: 18566400
[TBL] [Abstract][Full Text] [Related]
12. Effects of VEGFR1
Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
[TBL] [Abstract][Full Text] [Related]
13. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.
Hiratsuka S; Nakao K; Nakamura K; Katsuki M; Maru Y; Shibuya M
Mol Cell Biol; 2005 Jan; 25(1):346-54. PubMed ID: 15601855
[TBL] [Abstract][Full Text] [Related]
14. VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment.
Murakami M; Zheng Y; Hirashima M; Suda T; Morita Y; Ooehara J; Ema H; Fong GH; Shibuya M
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):658-64. PubMed ID: 18174461
[TBL] [Abstract][Full Text] [Related]
15. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
Li B; Sharpe EE; Maupin AB; Teleron AA; Pyle AL; Carmeliet P; Young PP
FASEB J; 2006 Jul; 20(9):1495-7. PubMed ID: 16754748
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
17. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
Roybal JD; Zang Y; Ahn YH; Yang Y; Gibbons DL; Baird BN; Alvarez C; Thilaganathan N; Liu DD; Saintigny P; Heymach JV; Creighton CJ; Kurie JM
Mol Cancer Res; 2011 Jan; 9(1):25-35. PubMed ID: 21115742
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1A receptor signaling facilitates tumor metastasis formation through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells.
Amano H; Ito Y; Ogawa F; Eshima K; Suzuki T; Oba K; Matsui Y; Kato S; Fukui T; Nakamura M; Kitasato H; Fukamizu A; Majima M
Am J Pathol; 2013 Feb; 182(2):553-64. PubMed ID: 23219751
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor 1 signaling facilitates gastric ulcer healing and angiogenesis through the upregulation of epidermal growth factor expression on VEGFR1+CXCR4 + cells recruited from bone marrow.
Sato T; Amano H; Ito Y; Eshima K; Minamino T; Ae T; Katada C; Ohno T; Hosono K; Suzuki T; Shibuya M; Koizumi W; Majima M
J Gastroenterol; 2014 Mar; 49(3):455-69. PubMed ID: 23982810
[TBL] [Abstract][Full Text] [Related]
20. Flt-1 signaling in macrophages promotes glioma growth in vivo.
Kerber M; Reiss Y; Wickersheim A; Jugold M; Kiessling F; Heil M; Tchaikovski V; Waltenberger J; Shibuya M; Plate KH; Machein MR
Cancer Res; 2008 Sep; 68(18):7342-51. PubMed ID: 18794121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
